Shopping Cart (0)
My Account

Shopping Cart
3 for 2 Offer SELECTBIO Conferences 3D-Culture, Organoids & Tox Screening Europe 2019Point-of-Care, Biosensors & Mobile Diagnostics Europe 2019Organ-on-a-Chip & Tissue-on-a-Chip Europe 2019Lab-on-a-Chip & Microfluidics Europe 2019Biofabrication & Biomanufacturing Europe 2019ePoster Award Prize

Business Courses

Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs): Technologies for Analysis and Market Opportunities


This Business Course is being held in Barcelona, Spain on the 05 March 2013 at 18:00-20:00

Price:



Enal Razvi Image
Enal Razvi
Managing Director,
Select Biosciences Inc

Scope of this Tutorial

This tutorial explores the emerging field of CTCs and CSCs from both a technology analysis as well as market/business perspective.

The data and analysis presented in this course is based upon Select Biosciences tracking of these emerging fields and Select Biosciences best-selling market & technology analysis report on this topic published in 2012 and 2013.

The value of this tutorial will be to researchers from academic institutions, commercial entities such as biotechnology and pharmaceutical companies seeking a thorough understanding of the scientific and business factors in this space, as well as industry participants such as venture capitalists, investors, business development professionals, and patent attorneys.

All attendees to this training course receive all PowerPoint files of the presentation material on disk with full rights to use them in their internal R&D presentations, business plans, and investor presentations.

Specific Topics Presented in this Tutorial

  • History and biological definition of CTCs and CSCs
  • Biological role of CTCs and CSCs in cancer progression and metastasis
  • CTC isolation and purification technologies: From Population-based Analysis to Single-Cell Analysis
  • Comparison of Technology Platforms and SWOT Analysis
  • Companies Developing Technologies in the Space
  • Survey of scientific research: Utility of CTCs in Cancer Diagnostics and Prognostics
  • Clinical Utility of CTCs
  • Market penetrance of different markers for characterizing CTCs and CSCs
  • Primary Market Research Data are Presented Characterizing the Current Research Methodologies Utilized, Market Penetrance of Different Approaches for CTC/CSC Analysis
  • Quantitative Market Metrics: Market Segmentation, Market Sizing, and Growth Rates of the Individual Market Segments
  • Market Opportunities for CTCs and CSCs in the Oncology Space and Emerging Themes
For more information about this training course, please e-mail Kathy Gray at k.gray@selectbio.com